Mesalazine-Induced Acute Pancreatitis in Inflammatory Bowel Disease Patients: A Systematic Review
Juan Pan,1,* Zuyi Li,1,* Chao Ye,2 Xiaojuan Zhang,1 Qiongliang Yang,1 Xu Zhang,1 Ya Zhou,3 Jianjun Zhang2 1Department of Pharmacy, Liuyang Hospital of Traditional Chinese Medicine, Changsha, Hunan, 410300, People’s Republic of China; 2Department of Pharmacy, Guangdong Provincial seco...
Saved in:
Main Authors: | Pan J, Li Z, Ye C, Zhang X, Yang Q, Zhou Y, Zhang J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-01-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/mesalazine-induced-acute-pancreatitis-in-inflammatory-bowel-disease-pa-peer-reviewed-fulltext-article-TCRM |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug therapy: dose-response relationship of oral mesalazine in
inflammatory bowel disease
by: C. J. J. Mulder, et al.
Published: (1998-01-01) -
Prospects of MMX Mesalazine in Routine Outpatient Treatment of Ulcerative Colitis
by: Yu. P. Uspenskiy, et al.
Published: (2022-03-01) -
Influence of Mesalazine on Ferroptosis-Related Gene Expression in In Vitro Colorectal Cancer Culture
by: Joanna Słoka, et al.
Published: (2025-01-01) -
Mesalazine solubility in supercritical carbon dioxide with and without cosolvent and modeling
by: Seyed Ali Sajadian, et al.
Published: (2025-01-01) -
Opioid-induced pancreatitis: A case study
by: Anuka Koul, et al.
Published: (2024-12-01)